Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in glioma-Reference-Cited by-同舟云学术

Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in glioma

Published:2023-06 Issue:6 Volume:41 Page:1134-1151.e10
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Ramachandran Mohanraj,Vaccaro Alessandra,van de Walle Tiarne,Georganaki Maria,Lugano Roberta,Vemuri Kalyani,Kourougkiaouri Despoina,Vazaios Konstantinos,Hedlund Marie,Tsaridou Georgia,Uhrbom Lene,Pietilä Ilkka,Martikainen Miika,van Hooren Luuk,Olsson Bontell Thomas,Jakola Asgeir S.,Yu Di,Westermark Bengt,Essand Magnus,Dimberg Anna

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference68 articles.

1. High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Stupp;Ann. Oncol.,2014

2. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;Stupp;N. Engl. J. Med.,2005

3. Maintenance therapy with tumor-treating fields plus temozolomide vs temozolomide alone for glioblastoma: a randomized clinical trial;Stupp;JAMA,2015

4. PD-1 inhibitors: do they have a future in the treatment of glioblastoma?;Khasraw;Clin. Cancer Res.,2020

5. Effect of nivolumab vs bevacizumab in patients with recurrent glioblastoma: the CheckMate 143 phase 3 randomized clinical trial;Reardon;JAMA Oncol.,2020

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vivo dendritic cell reprogramming for cancer immunotherapy;Science;2024-09-05

2. Oncolytic herpes simplex virus propagates tertiary lymphoid structure formation via CXCL10/CXCR3 to boost antitumor immunity;Cell Proliferation;2024-09

3. Macrophages and tertiary lymphoid structures as indicators of prognosis and therapeutic response in cancer patients;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

4. Targeting the tumour vasculature: from vessel destruction to promotion;Nature Reviews Cancer;2024-08-29

5. Tertiary lymphoid structures in diseases: immune mechanisms and therapeutic advances;Signal Transduction and Targeted Therapy;2024-08-28